Company Cellumed Co.,Ltd.

Equities

A049180

KR7049180003

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical Devices & Implants

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
1,665 ^KRW	-0.60%		-3.20%	-22.56%

03-21	Cellumed Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-07	Cellumed Co.,Ltd. announced that it has received KRW 10.000000362 billion in funding	CI

CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Companyâs products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.

Number of employees: 103

KRW in Million	2022	Weight	2023	Weight	Delta
Construction Machinery and Equipment 80.1 %	90,385	74.0 %	76,519	80.1 %	-15.34%
Medical Treatment 14.8 %	14,644	12.0 %	14,130	14.8 %	-3.51%
Services & Others 4.2 %	6,556	5.4 %	3,969	4.2 %	-39.45%
Cosmetics Items 0.6 %	9,763	8.0 %	535	0.6 %	-94.52%
Wholesale and Retail 0.4 %	738	0.6 %	400	0.4 %	-45.80%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 98.4 %	118,743	97.3 %	94,030	98.4 %	-20.81%
Overseas 1.6 %	3,342	2.7 %	1,523	1.6 %	-54.44%

Managers	Title	Age	Since
In-Soo Yoo CEO	Chief Executive Officer	62	-

Members of the board	Title	Age	Since
In-Soo Yoo CEO	Chief Executive Officer	62	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	49,234,444	39,968,419 ( 81.18 %)	9,008 ( 0.0183 %)	81.18 %

Name	Equities	%	Valuation
INSCOBEE., INC. 17.71 %	8,530,021	17.71 %	11 M ₩
Yu-myoung Hyun 1.196 %	575,900	1.196 %	720 866 ₩
Apimeds, Inc. 0.9966 %	480,000	0.9966 %	600 826 ₩
Young-duk Lee 0.8922 %	429,700	0.8922 %	537 864 ₩
Hyo-jae Hyun 0.8413 %	405,200	0.8413 %	507 197 ₩
Ja-gap Koo 0.2701 %	130,073	0.2701 %	162 815 ₩
Yong-Hwe Kim 0.1597 %	76,923	0.1597 %	96 286 ₩
CELLUMED CO.,LTD. 0.0187 %	9,008	0.0187 %	11 275 ₩
DFA Australia Ltd. 0.005186 %	2,498	0.005186 %	3 127 ₩

Name	Equities	%	Valuation
CELLUMED CO.,LTD. 0.02%	9,008	0.02%	11,275 $

CELLUMED Co., Ltd.

Unit 402, Ace Techno Tower 9-cha 130 Digital-ro

08589, Seoul

http://www.cellumed.co.kr

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
CELLUMED CO.,LTD.	-22.56%	61.21M
STRYKER CORPORATION	+11.76%	127B
SMITH & NEPHEW PLC	-5.10%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.04B
GLAUKOS CORPORATION	+38.12%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-23.70%	4.72B
AXONICS, INC.	+8.55%	3.45B
ENOVIS CORPORATION	-6.44%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.04B

Medical Devices & Implants